Abstract:Introduction Influenza A virus (IAV) infection predisposes to subsequent bacterial superinfection in the lungs that promotes a greater pneumonia severity. Among host innate immune players, alveolar macrophages (AM) are essential for lung protection against bacteria. From mice studies, the prominent paradigm suggests that influenza infection induces almost total mouse AM (mAM) depletion, resulting in an increased vulnerability to secondary bacterial infection. Nevertheless, the potential IAV-induced AM depletion as never been study in human. The aim of the study is to characterize the AM number in newly influenza-infected human and to compare the ability of IAV to infect AM from mouse and human origin. Methods Because the observation of AM depletion in mice was described with non-translational influenza inoculum (too high), we infected c57BL/6J mice with a mild inoculum of influenza A virus (H3N2, 10 PFU) by intranasal route and measured the AM count. Next, we described a case report of a hospital-acquired influenza infection in a patient with pre and post-infection bronchoalveolar lavage (BAL) procedures. Then, we extracted data from 2 published clinical investigations assessing BAL in critical care unit and we performed an ancillary study included patients with a PCR-confirmed influenza infection and a BAL performed within the four firth days of ICU admission (AM expressed in mean ± SEM). Finally, using ex vivo AMs models, we compared the ability of IAV to infect mouse and human AMs and the subsequence consequences regarding inflammatory mediator production. Results Using mice model of mild IAV infection, we demonstrated that despite the low IAV inoculum the AM count dropped drastically in the BAL fluid from the fourth day (reduction of 64% from baseline) and was maximal at the seventh day post-infection (reduction of 90%). At the contrary, a patient newly infected by IAV (4 days after the onset of the symptoms) did not present significant modification of the AM count (> 200,000 cells/mL before and after the IAV infection). Next, we assessed the cellularity of BAL of influenza-infected critically ill patients ( n = 15) and controls ( n = 7), thanks to the ancillary study described. The absolute AM count was respectively 3.8 × 10 5 ± 1.5 × 10 5 cells/mL in influenza-infected and 2.8 × 10 5 ± 0.6 × 10 5 cells/mL in controls. In ex vivo AM models, we demonstrated that IAV infects, replicates, and induces inflammatory response similarly in AM of mouse and human origins. Conclusion We demonstrated that IAV-induced AM depletion in mouse but not in human. We did not observe difference in vitro regarding the viral replication and subsequent inflammatory response in mAM and mAM. It is unlikely that the secondary bacterial infections are explained by AM depletion in influenza-infected human.

Monocyte-derived alveolar macrophages autonomously determine severe outcome of respiratory viral infection

Induction of Autonomous Memory Alveolar Macrophages Requires T Cell Help and is Critical to Trained Immunity

Fetal monocytes possess increased metabolic capacity and replace primitive macrophages in tissue macrophage development

A Functional Assessment of Fetal Liver and Monocyte-Derived Macrophages in the Lung Alveolar Environment

Progress in Alveolar Macrophages

Shaping of the alveolar landscape by respiratory infections and long-term consequences for lung immunity

Alveolar Macrophages: Adaptation to Their Anatomic Niche during and after Inflammation

Effects of Influenza on Alveolar Macrophage Viability Are Dependent on Mouse Genetic Strain

Influenza induces depletion of alveolar macrophages in mice but not in human

Intestinal microbiota programming of alveolar macrophages influences severity of respiratory viral infection

Zom-biecoming: Single-Cell RNA-sequencing reveals senescence-like features of alveolar macrophages during aging

Bacterial Colonization Dampens Influenza-Mediated Acute Lung Injury Via Induction of M2 Alveolar Macrophages

Zom-biecoming: Single-Cell RNA-seq reveals senescence-like features of alveolar macrophages during aging

Multiple Death Pathways of Neutrophils Regulate Alveolar Macrophage Proliferation

Thorough assessment of primary cell cultures for murine and human alveolar macrophages

Human alveolar macrophages display marked hypo-responsiveness to IFN-γ in both proteomic and gene expression analysis

The Aging Microenvironment Shapes Alveolar Macrophage Identity in Aging

The deadly dance of alveolar macrophages and influenza virus

Monocyte‐Derived Macrophages Induce Alveolar Macrophages Death via TNF‐α in Acute Lung Injury

Interstitial Macrophages Mediate Efferocytosis of Alveolar Epithelium During Influenza Infection

The guardians of pulmonary harmony: alveolar macrophages orchestrating the symphony of lung inflammation and tissue homeostasis